The a2 Milk Company
New Zealand public dairy company
The a2 Milk Company
| Type | Public |
|---|---|
| Traded as | ASX: A2M, NZX: ATM |
| Key people | David Hearn (Chairman), David Bortolussi (CEO) |
| Industry | Dairy |
| Products | Milk, Infant formula, Cream, Yogurt |
| Revenue | |
| Operating income | |
| Net income | |
| Employees | 300+ (2020) |
| Website | [thea2milkcompany.com Official website] |
The a2 Milk Company is a New Zealand-based public dairy company that specializes in the production and marketing of A2 protein-only milk and related products. The company was founded in 2000 by Corran McLachlan, a scientist who discovered that proteins in milk could be categorized into A1 and A2 types. The a2 Milk Company focuses on producing milk that contains only the A2 type of beta-casein protein, which is believed to be easier to digest for some people.
History
The a2 Milk Company was established in 2000 by Corran McLachlan and Howard Paterson. The company initially focused on the New Zealand market but has since expanded its operations internationally, including in Australia, China, and the United States. The company was listed on the New Zealand Exchange (NZX) in 2004 and later on the Australian Securities Exchange (ASX) in 2015.
Products
The a2 Milk Company offers a range of dairy products, including:
These products are marketed as being easier to digest for people who may experience discomfort from consuming regular milk that contains both A1 and A2 proteins.
Market Expansion
The a2 Milk Company has seen significant growth in recent years, particularly in the Chinese market, where there is a high demand for premium infant formula. The company has also expanded its presence in the United States, where it has partnered with major retailers to distribute its products.
Controversies
The a2 Milk Company has faced criticism and legal challenges from competitors and regulatory bodies. Some of these controversies revolve around the health claims made about A2 protein-only milk and its purported benefits over regular milk.
See also
References
External links
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD